View Single Post
Old 12-08-2011, 06:30 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 19,720
Ixabepilone-sunitinib combination holds potential against chemotherapy-resistant ovar

The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.

More...
News is offline   Reply With Quote